PARAMETRIC PORTFOLIO ASSOCIATES LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$5,406,000
-9.9%
277,250
-24.6%
0.00%0.0%
Q4 2021$6,001,000
-19.9%
367,732
+36.7%
0.00%
-25.0%
Q3 2021$7,496,000
-5.8%
269,068
+0.2%
0.00%0.0%
Q2 2021$7,955,000
+9.2%
268,401
+3.0%
0.00%0.0%
Q1 2021$7,285,000
-1.0%
260,653
+0.4%
0.00%
-20.0%
Q4 2020$7,360,000
-1.2%
259,694
-12.3%
0.01%0.0%
Q3 2020$7,446,000
+20.3%
296,191
+16.9%
0.01%0.0%
Q2 2020$6,188,000
+55.1%
253,390
-6.0%
0.01%
+25.0%
Q1 2020$3,990,000
-27.0%
269,579
-19.9%
0.00%0.0%
Q4 2019$5,465,000
+65.0%
336,729
+32.2%
0.00%
+33.3%
Q3 2019$3,313,000
+129.8%
254,808
+129.1%
0.00%
+200.0%
Q2 2019$1,442,000
+59.3%
111,215
+93.7%
0.00%0.0%
Q1 2019$905,000
-14.5%
57,405
+9.1%
0.00%0.0%
Q4 2018$1,059,000
-9.0%
52,618
+12.4%
0.00%0.0%
Q3 2018$1,164,000
+13.3%
46,834
+25.2%
0.00%0.0%
Q2 2018$1,027,000
-54.2%
37,405
-48.7%
0.00%
-50.0%
Q1 2018$2,244,000
-13.9%
72,849
-0.0%
0.00%
-33.3%
Q4 2017$2,605,000
+169.7%
72,855
+107.9%
0.00%
+200.0%
Q3 2017$966,000
+25.6%
35,047
+20.4%
0.00%0.0%
Q2 2017$769,000
+34.9%
29,112
+6.2%
0.00%0.0%
Q1 2017$570,000
+6.3%
27,401
+5.9%
0.00%0.0%
Q4 2016$536,000
+58.6%
25,877
+24.2%
0.00%0.0%
Q3 2016$338,000
+17.8%
20,837
-1.1%
0.00%
Q2 2016$287,000
-28.2%
21,068
-8.1%
0.00%
-100.0%
Q1 2016$400,00022,9240.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders